Telomeres are repetitive, noncoding sequences that cap the ends of linear chromosomes. They consist of hexameric nucleotide sequences (TTAGGG in humans) repeated hundreds to thousands of times. Telomeres protect the protein-coding sequences of DNA on
Advertisement
The Scientist
Most Recent
A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. In order to replicate the structure of an enzyme’s transition state, whic
A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.
Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.
Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.
From breast milk stem cells to bone repair, this year’s EB conference held a number of exciting advances that could one day be translated into therapies.
Swedish researchers have discovered that patients with the neurodegenerative disorder had half the normal expected risk of developing tumors.
A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.
Extra inches may mean a higher chance of getting ovarian cancer.
A roundup of recent research announced this week at the annual conference of the American Association for Cancer Research (AACR).
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
